Research Proposes Dimensional Approach for Understanding Depression

The findings indicate that these clinical dimensions are associated with distinct connectivity patterns, suggesting that depression is not a uniform condition concerning brain function. In clinical settings, major depressive disorder is diagnosed based on symptom combinations specified by diagnostic manuals like the "Diagnostic and Statistical Manual of Mental Disorders," which allows for variability under a single diagnosis. This variability can hinder the identification of consistent brain biomarkers and the prediction of treatment responses.

Dr. Marta Cano, a co-author of the study, noted that using one diagnostic category for patients with diverse symptoms complicates the search for brain correlates and effective treatments. She emphasized that analyzing depression through specific clinical dimensions enables a clearer examination of the brain mechanisms related to each symptom, enhancing understanding of the disorder's varying experiences among patients.

The review highlights four clinical dimensions that have been explored through resting-state functional magnetic resonance imaging: anhedonia, rumination, insomnia, and suicidal behavior. Each dimension exhibits unique connectivity profiles, further supporting that depression has a diverse neurobiological basis.

For anhedonia, which is characterized by difficulty in experiencing pleasure, the review identifies two components with different neurobiological profiles. Consummatory anhedonia correlates with decreased connectivity between the ventral striatum and prefrontal cortex, while anticipatory anhedonia reveals more complex connectivity patterns, indicating reliance on different brain circuits.

Rumination is characterized as repetitive, self-referential thinking. The review differentiates between maladaptive rumination, related to persistent negative thoughts, and reflective rumination that is more analytical. Studies show brooding involves increased connectivity in the default mode network, while reflective rumination engages cognitive control networks.

Insomnia is described as a central dimension of depression, with studies documenting alterations in the connectivity of key parts of the default mode network, such as the hippocampus and medial prefrontal cortex, highlighting its specific neurobiological basis in depression.

Suicidal behavior is framed as a continuum from ideation to attempts, with connectivity alterations in the orbitofrontal cortex noted. Suicidal ideation correlates with cognitive control and self-referential circuit changes, whereas suicide attempts are more tied to emotional pain processing regions.

Dr. Narcís Cardoner, another co-author, stated that the findings indicate that depression encompasses a set of clinical dimensions linked to partly distinct brain circuits rather than a singular condition. This dimensional perspective may illuminate the varying trajectories of patients with identical diagnoses and their diverse responses to treatment.

The authors argue that identifying connectivity patterns linked to specific symptoms is crucial for advancing personalized psychiatry. They propose that this approach could lead to the development of brain biomarkers with prognostic value and targeted treatments, including neuromodulation strategies. They emphasize that further research is necessary for these insights to impact clinical practice, paving the way for a brain-centered psychiatry aimed at improving depression diagnosis, prognosis, and treatment.

The article titled "Resting-state functional neuroimaging biomarkers in depression: toward a dimensional approach for personalized diagnosis and treatment" was authored by Daniel Porta-Casteràs et al and published in Translational Psychiatry.